Skip to content

Clinical trials

Completed Hemorrhage trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Status: Completed Country / region: South Korea Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20071
20091
20121
20132
20145
20153
20171
20181
20193
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Hospital4
Pfizer2
Yonsei University2
Ajou University School of Medicine1
Asan Medical Center1
AstraZeneca1
Boehringer Ingelheim1
Chonnam National University Hospital1
Gangnam Severance Hospital1
Gyeongsang National University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage23
Acute Coronary Syndrome1
Blood Loss, Surgical1
Cataplexy1
Coronary Artery Disease1
Diabetic Retinopathy1
Dyspnea1
Heart Defects, Congenital1
Hemophilia A1
Hemophilia B1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.